Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Trending on PharmExec

The Origins of Nuvation Bio’s Deal with Daichii Sankyo for the Rights to Safusidenib in Japan

Pharma M&A Roundup: AstraZeneca Enters License Deal with Dizal Pharmaceutical, Chai Discovery Enters Collaboration with Novartis, Innovent Biologics Enters License Agreement with Spero Therapeutics

Pharmaceutical Executive: March 2026 Interactive Digital Edition

Articles in this issue

Trending on PharmExec

The Origins of Nuvation Bio’s Deal with Daichii Sankyo for the Rights to Safusidenib in Japan

Pharma M&A Roundup: AstraZeneca Enters License Deal with Dizal Pharmaceutical, Chai Discovery Enters Collaboration with Novartis, Innovent Biologics Enters License Agreement with Spero Therapeutics

FDA Approves Leqembi Iqlik Subcutaneous Injection for Early Alzheimer’s Disease

Educating Patients About GLP-1s: Q&A with Kristen Hartzell, PharmD

Nuvation Bio’s Approach to Building a Compelling Narrative